Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Topical Simvastatin for Treating Infantile Hemangioma
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Joyce Teng
- Target Recruit Count
- 12
- Registration Number
- NCT06273111
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
Computational Drug Repurposing for All EBS Cases
Recruiting
- Conditions
- HealthyEpidermolysis BullosaEpidermolysis Bullosa SimplexGenetic Skin DiseaseEpidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Joyce Teng
- Target Recruit Count
- 60
- Registration Number
- NCT03269474
- Locations
- 🇺🇸
Pediatric Dermatology Clinic at Stanford Children's Hospital, Palo Alto, California, United States
News
No news found